RxSight (NASDAQ:RXST) Stock Rating Upgraded by Zacks Investment Research

RxSight (NASDAQ:RXST – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Tuesday, Zacks.com reports. According to Zacks, “RxSight Inc. is a commercial-stage medical technology company focuses on patients following cataract surgery. The RxSight Light Adjustable Lens system, comprised of […]

Related Keywords

New York ,United States ,California ,Aliso Viejo ,Canada ,American ,Thomson Reuter ,York State Common Retirement Fund ,Zacks Investment Research ,Rxsight Company Profile Get Rating ,Rxsight Inc ,Deutsche Bank ,Nasdaq ,Needham Company ,American International Group Inc ,Royal Bank ,Get Rating ,Rxsight Light Adjustable Lens ,Rxsight Light Delivery Device ,State Teachers Retirement System ,International Group ,Sight Company Profile ,Rxsight ,Nasdaq Rxst ,Rxst ,Medical ,Upgrade ,